HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing Jin Selected Research

Hepatocellular Carcinoma (Hepatoma)

4/2024Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
1/2023SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth.
12/2022Phase 2 Evaluation of Neoadjuvant Intensity-Modulated Radiotherapy in Centrally Located Hepatocellular Carcinoma: A Nonrandomized Controlled Trial.
6/2022Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements.
2/2019MiR-92b targets p57kip2 to modulate the resistance of hepatocellular carcinoma (HCC) to ionizing radiation (IR) -based radiotherapy.
1/2017Observation of different tumor motion magnitude within liver and estimate of internal motion margins in postoperative patients with hepatocellular carcinoma.
5/2016Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma.
5/2016Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence.
12/2015Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vessels.
10/2014Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing Jin Research Topics

Disease

171Neoplasms (Cancer)
04/2024 - 10/2002
47Inflammation (Inflammations)
01/2024 - 08/2010
44Breast Neoplasms (Breast Cancer)
11/2023 - 07/2006
39Infections
04/2024 - 06/2002
32Rectal Neoplasms (Rectal Cancer)
04/2024 - 10/2005
29Stomach Neoplasms (Stomach Cancer)
01/2024 - 05/2013
21Neoplasm Metastasis (Metastasis)
04/2024 - 03/2007
18Lung Neoplasms (Lung Cancer)
04/2024 - 02/2009
14Hepatocellular Carcinoma (Hepatoma)
04/2024 - 12/2002
14Carcinoma (Carcinomatosis)
01/2023 - 09/2007
14Malaria
10/2022 - 11/2014
14Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 11/2006
13COVID-19
01/2024 - 01/2020
13Carcinogenesis
01/2022 - 08/2005
12Fibrosis (Cirrhosis)
04/2024 - 06/2011
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 01/2013
11Stroke (Strokes)
03/2024 - 01/2016
11Lymphoma (Lymphomas)
03/2024 - 01/2006
11Body Weight (Weight, Body)
12/2023 - 06/2013
11Esophageal Neoplasms (Esophageal Cancer)
03/2023 - 10/2004
11T-Cell Lymphoma (Lymphoma, T Cell)
12/2013 - 01/2006
10Adenocarcinoma
04/2024 - 12/2004
10Glioblastoma (Glioblastoma Multiforme)
11/2023 - 01/2017
10Insulin Resistance
01/2023 - 01/2014
10Ischemic Stroke
01/2022 - 05/2013
9Liver Diseases (Liver Disease)
04/2024 - 12/2005
8Hypoxia (Hypoxemia)
01/2023 - 09/2013
8Huntington Disease (Huntington's Disease)
10/2022 - 07/2012
7Pain (Aches)
05/2024 - 08/2019
7Thrombosis (Thrombus)
04/2024 - 07/2016
7Nasopharyngeal Carcinoma
02/2024 - 03/2007
7Reperfusion Injury
01/2023 - 01/2016
7Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 06/2015
7Hemorrhage
10/2022 - 08/2016
6Asthma (Bronchial Asthma)
12/2024 - 08/2004
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 01/2015
6IGA Glomerulonephritis (IGA Nephropathy)
01/2024 - 01/2021
6Ischemia
01/2023 - 01/2008
6Type 2 Diabetes Mellitus (MODY)
01/2023 - 01/2017
6Disease Progression
10/2022 - 01/2006
6Fatigue
05/2022 - 11/2008
6Heart Failure
05/2022 - 10/2006
6Sarcoma (Soft Tissue Sarcoma)
04/2022 - 04/2007
6Colitis
03/2022 - 01/2016
6Virus Diseases (Viral Diseases)
01/2022 - 06/2002
5Obesity
04/2024 - 05/2010

Drug/Important Bio-Agent (IBA)

79Proteins (Proteins, Gene)FDA Link
03/2024 - 05/2004
39Biomarkers (Surrogate Marker)IBA
12/2023 - 08/2010
20Messenger RNA (mRNA)IBA
03/2023 - 03/2007
19CytokinesIBA
03/2024 - 05/2008
19DNA (Deoxyribonucleic Acid)IBA
02/2023 - 06/2002
17Glucose (Dextrose)FDA LinkGeneric
01/2024 - 01/2008
16Long Noncoding RNAIBA
04/2024 - 05/2016
15VaccinesIBA
10/2022 - 01/2015
14RNA (Ribonucleic Acid)IBA
05/2024 - 07/2006
14Small Interfering RNA (siRNA)IBA
03/2024 - 10/2010
13MicroRNAs (MicroRNA)IBA
02/2024 - 11/2012
13Therapeutic UsesIBA
03/2023 - 01/2008
13AntibodiesIBA
07/2022 - 08/2012
12EnzymesIBA
01/2024 - 07/2008
12Capecitabine (Xeloda)FDA Link
12/2023 - 03/2006
11AntioxidantsIBA
10/2022 - 01/2014
10AntigensIBA
07/2022 - 06/2013
9Anti-Bacterial Agents (Antibiotics)IBA
02/2024 - 06/2010
9Cisplatin (Platino)FDA LinkGeneric
12/2023 - 01/2015
8LipidsIBA
12/2023 - 07/2015
8Carrier Proteins (Binding Protein)IBA
05/2022 - 09/2015
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024 - 03/2008
7Transcription Factors (Transcription Factor)IBA
01/2024 - 07/2006
7Insulin (Novolin)FDA Link
12/2023 - 01/2014
7Triglycerides (Triacylglycerol)IBA
12/2023 - 05/2010
7LigandsIBA
07/2022 - 04/2013
7Immunoglobulin G (IgG)IBA
07/2022 - 10/2012
7Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 02/2005
7Interleukin-10 (Interleukin 10)IBA
11/2021 - 11/2011
72- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
06/2021 - 06/2014
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2020 - 01/2013
6Oxygen (Dioxygen)IBA
04/2024 - 03/2016
6Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2024 - 11/2008
6Interleukin-6 (Interleukin 6)IBA
12/2023 - 01/2020
6Antiviral Agents (Antivirals)IBA
10/2023 - 03/2016
6SmokeIBA
01/2023 - 01/2008
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 04/2007
6Neutralizing AntibodiesIBA
10/2022 - 12/2015
6Neuroprotective AgentsIBA
10/2022 - 05/2013
6Clopidogrel (Plavix)FDA Link
03/2021 - 01/2015
5Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2024 - 05/2004

Therapy/Procedure

83Radiotherapy
04/2024 - 10/2002
68Therapeutics
02/2024 - 10/2004
32Drug Therapy (Chemotherapy)
04/2024 - 03/2005
26Neoadjuvant Therapy
04/2024 - 10/2004
25Chemoradiotherapy
12/2023 - 10/2004
22Immunotherapy
04/2024 - 01/2020
14Mastectomy (Mammectomy)
01/2023 - 11/2009
11Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
12/2022 - 03/2012
11Aftercare (After-Treatment)
11/2022 - 03/2005
10Adjuvant Chemotherapy
10/2022 - 10/2005
9Segmental Mastectomy (Lumpectomy)
11/2023 - 09/2014
8Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2024 - 11/2008
7Oral Administration
02/2022 - 01/2008